Recent Articles
IPOs Remain At Historic Lows In The Third Quarter
The number of companies going public on United States exchanges amounted to 35 in the third quarter, which represented a 16.7% uptick from the year-ago quarter (30 IPOs). Despite the increase, this number still trails the average third quarter IPO count going back to 2000 (39 IPOs). The Q3 amount also represented an increase from […]
Top 3 Predictions For The Market In 2017
Some major themes have developed in the market this year that will carry over into 2017 and change how investors will profit in the market. Bret Jensen shares his top three strategies for which stocks will win and which will lose in 2017. The third quarter has officially wound to a close. The market has […]
4 Must-Own Biotech Stocks As The Sector Comes Charging Back
Up 20% over the last three months, the biotech sector has come roaring back with a vengeance. Given the positive outlook for this sector, Bret Jensen shares his four “must-own” picks through year-end. After three quarters of significantly underperforming the overall market, the biotech sector has roared back in a big way so far in […]
Buy These 3 Stocks Insiders Love
When insiders step up and put millions of their own dollars on the line to purchase company stock, investors should take notice. Don’t wait to only then see these stocks on CNBC rocketing up double-digits, buy shares today. After over two decades of successfully investing in the volatile and lucrative small biotech space, I have […]
The Next 3 Major Biotech Takeover Targets
After record years for deal volume in both 2014 and 2015 in the biotech and pharma industries, M&A transactions have posted a significant decline in the volume of deals so far in 2016 across these industries. As of late August, transactions based on dollar volume were down almost 65% from the same period in 2015. […]
Sell These 5 Stocks On The Verge Of Bankruptcy
These stocks have serious red flags and are ticking time bombs in your portfolio. Several companies from our 2014 and 2015 watchlists are already bankrupt or very close, and the companies profiled today are likely on the same track. Dump these losers immediately. Bankruptcy is a scary thing but a natural part of the economic […]
The 6 Biggest Mistakes New Investors Make
Investing is exciting. When you first enter the world of stocks, bonds, real estate, and the limitless other capital investment options, all you can think about is the sheer potential of your financial decisions. Unfortunately, your lack of experience may limit that potential, or sabotage it all together. There’s no way for a novice investor […]
Investors Believe The Fed Will Hike Interest Rates Again
The possibility of a US recession is diminishing, and the Federal Reserve is on track to hike interest rates twice a year for the foreseeable future that’s according to Bank of America Merrill Lynch’s most recent US Credit Investor Survey. Bank of America’s credit survey gives an interesting insight into the world of the bank’s […]
3 Biotech Stocks That Can Double Before The End Of 2016
And, that is no exaggeration, these three biotech stocks all have near-term catalysts right around the corner that will send their currently undervalued share prices soaring when positive. Grab shares today because the catalysts we’re targeting for growth start happening in September. One of the keys to investing in the small cap portion of the […]
Don’t Trust Your Gut: Trust A System
In August of 1971, Ray Dalio – now one of the most respected hedge fund billionaires on Wall Street – was a lowly clerk working on the Street. By coincidence, Dalio was starting his career during one of history’s critical turning points. President Nixon had just taken the dollar off of the gold standard. Dalio’s […]
Go Long Value, Rotate Out Of Growth Stocks
“Low interest rates have made it very cheap for companies to grow. Higher ROI will outperform when capital becomes more expensive.” David Poppe, Sequoia Fund’s CEO, on why value stocks have underperformed growth stocks. According to Renaissance Capital, there were 192 biotech IPOs in the past 5 years, raising more than $14.7 billion. Most of […]
